5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 19.96▼ | 19.84▼ | 19.70▲ | 18.92▲ | 17.96▲ |
MA10 | 19.99▼ | 19.65▲ | 19.37▲ | 18.14▲ | 19.45▲ |
MA20 | 19.91▼ | 19.31▲ | 19.02▲ | 17.60▲ | 20.81▼ |
MA50 | 19.61▲ | 18.90▲ | 18.52▲ | 19.48▲ | 22.85▼ |
MA100 | 19.25▲ | 18.40▲ | 17.45▲ | 21.01▼ | 19.48▲ |
MA200 | 18.95▲ | 17.22▲ | 18.41▲ | 22.96▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.037▼ | 0.055▲ | 0.080▲ | 0.426▲ | -0.300▼ |
RSI | 49.415▼ | 65.348▲ | 67.298▲ | 57.363▲ | 45.564▼ |
STOCH | 55.701 | 91.011▲ | 87.251▲ | 79.862 | 42.532 |
WILL %R | -89.706▼ | -19.614▲ | -14.734▲ | -5.346▲ | -33.704 |
CCI | -147.440▼ | 99.752 | 130.002▲ | 133.485▲ | -35.406 |
Wednesday, April 30, 2025 10:38 PM
2-Year U.S. Treasury Note Continuous Contract $104.117 0.043 0.04% 5-Year U.S. Treasury Note Continuous Contract $109.344 0.148 0.14% 10-Year U.S. Treasury Note Continuous Contract $112.438 0.219 ...
|
Tuesday, April 22, 2025 11:54 AM
Enliven Therapeutics is a clinical-stage concern that has two candidates in its pipeline targeting oncology indications. Learn more on ELVN stock here.
|
Wednesday, April 16, 2025 05:00 PM
Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 18.98 | 20.155 | 18.57 | 19.85 | 216,036 |
30/04/25 | 18.41 | 19.219 | 17.82 | 18.94 | 157,800 |
29/04/25 | 18.53 | 19.04 | 18.24 | 18.67 | 179,049 |
28/04/25 | 18.19 | 19.185 | 17.81 | 18.91 | 318,922 |
25/04/25 | 18.05 | 18.40 | 17.4583 | 18.21 | 124,976 |
24/04/25 | 17.72 | 18.57 | 17.36 | 18.30 | 249,987 |
23/04/25 | 18.65 | 19.61 | 17.71 | 17.77 | 180,903 |
22/04/25 | 16.45 | 18.225 | 16.45 | 17.97 | 508,010 |
21/04/25 | 16.15 | 16.82 | 15.44 | 16.22 | 282,227 |
17/04/25 | 16.12 | 16.854 | 16.065 | 16.53 | 171,768 |
|
|
||||
|
|
||||
|
|